Kwality Pharmaceuticals Q2 Results FY27: PAT Jumps 105.59% to Rs 29.03 Cr, Revenue Rs 181.22 Cr

Kwality Pharmaceuticals Ltd (KPL) Q2 Results FY27 announced on 12 November 2026, covering the company's financial performance for the July to September quarter. The results date brought Consolidated revenue of Rs 181.22 Cr and PAT of Rs 29.03 Cr. Kwality Pharmaceuticals Q2 Results FY27 therefore point to a year on year rise in both lines, and these consolidated results are unpacked below.

This results analysis covers the financial highlights, business drivers, outlook and risks behind Kwality Pharmaceuticals Q2 Results. Univest tracks these figures so readers can compare them quickly, and the table that follows sets out each metric against the same quarter last year.

Click Here – Get Free Investment Predictions

Kwality Pharmaceuticals Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 181.22 Cr	Rs 111.05 Cr	+63.19% YoY
Operating Profit	Rs 49.8 Cr	Rs 25.35 Cr	+96.45% YoY
Net Profit (PAT)	Rs 29.03 Cr	Rs 14.12 Cr	+105.59% YoY

Source: company filing for Kwality Pharmaceuticals Q2 Results FY27, 12 November 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Kwality Pharmaceuticals Q2 Results: What Stands Out

• Revenue Rs 181.22 Cr: sales climbed 63.19% from Rs 111.05 Cr in the same quarter last year, a sharp YoY growth print for the business.
• Net profit Rs 29.03 Cr: profit after tax more than doubled from Rs 14.12 Cr, a rise of 105.59% over the year earlier quarter.
• Operating Profit Rs 49.8 Cr: this line grew 96.45% from Rs 25.35 Cr, so it moved nearly in step with net profit and revenue.
• Net profit margin 16.0%: the margin improved from 12.7% in the comparison quarter, measured on the same consolidated basis.
• Four quarters of growth: Kwality Pharmaceuticals Q2 Results FY27 extend a run in which revenue has risen in each of the last 4 quarters.
• Risk headline: quarterly net profit has been volatile, which leads into the detailed performance analysis that follows.

Kwality Pharmaceuticals Q2 Results FY27: Performance Analysis

The numbers show revenue of Rs 181.22 Cr, net profit of Rs 29.03 Cr and Operating Profit of Rs 49.8 Cr, all higher than a year ago. Kwality Pharmaceuticals Q2 Results FY27 therefore record YoY growth of 63.19%, 105.59% and 96.45% respectively on a consolidated basis.

Revenue rose from Rs 111.05 Cr to Rs 181.22 Cr, while net profit moved from Rs 14.12 Cr to Rs 29.03 Cr and Operating Profit from Rs 25.35 Cr to Rs 49.8 Cr. In this results analysis, profit grew faster than revenue, which is why the net profit margin reached 16.0% from 12.7%. These are the quarterly results that investors will weigh first.

Readers following Kwality Pharmaceuticals Q2 Results can use the Univest Screener to place this quarter beside earlier periods. The figures confirm what changed but do not establish the specific cause, so the next step is the disclosed drivers, and those business factors come next.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The business factors start with sales, as revenue grew 63.2% year on year to Rs 181.22 Cr in the latest quarter. This is the largest single move in the disclosed set and anchors the rest of the quarter.

Net Profit Gain – Net profit rose 105.6% year on year to Rs 29.03 Cr, and Kwality Pharmaceuticals Q2 Results FY27 carry that gain into the bottom line of these quarterly results, as the Financial Highlights table shows.

Margin and Revenue Streak – The net profit margin improved to 16.0% from 12.7% in the comparison quarter, and revenue has risen in each of the last 4 quarters, which are the two remaining disclosed factors.

FY27 Outlook After Kwality Pharmaceuticals Q2 Results

FY27 full-year results will depend on subsequent quarters and on disclosed sector conditions. Kwality Pharmaceuticals Q2 Results FY27 give a reference point of Rs 181.22 Cr in revenue and Rs 29.03 Cr in net profit, and each new filing will show how that base develops.

This results analysis suggests investors will track whether net profit holds near its latest level and whether the 16.0% net profit margin is repeated in later filings. Updates can be followed in the Univest app, and that watch list leads naturally to the risks that deserve equal attention.

Key Risks to Watch After Kwality Pharmaceuticals Q2 Results FY27

Volatile Quarterly Profit

Quarterly net profit has been volatile, ranging from Rs 14.12 Cr to Rs 29.03 Cr over the last 5 quarters. Kwality Pharmaceuticals Q2 Results FY27 sit at the top of that range, so later filings will show whether the YoY growth is sustained.

Slipping Annual Per-Share Profit

Annual profit per share has slipped between FY22 and FY26, which means the strong quarterly gain sits against a weaker multi-year record that investors should keep in view alongside the latest numbers.

Negative Multi-Year Growth

Annual per-share profit growth was negative from FY22 to FY26, falling 13.4% a year, so the latest consolidated quarter is best read together with this longer trend and not on its own.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Kwality Pharmaceuticals Q2 Results FY27 show revenue of Rs 181.22 Cr and net profit of Rs 29.03 Cr, with every supplied line higher than a year ago. These consolidated results and quarterly results also sit beside a longer-term risk record, so later filings matter. Readers tracking Kwality Pharmaceuticals Q2 Results should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Kwality Pharmaceuticals Q2 Results FY27

What are Kwality Pharmaceuticals Q2 Results FY27?

Ans. Kwality Pharmaceuticals Q2 Results FY27 cover the July to September 2026 quarter, with revenue of Rs 181.22 Cr. Alongside this, net profit came in at Rs 29.03 Cr, as the opening Quick Answer summarises.

What is the results date for Kwality Pharmaceuticals Q2 Results FY27?

Ans. Kwality Pharmaceuticals Q2 Results FY27 were declared on 12 November 2026, which is the results date. This date is stated in the introduction, so readers can match it with the exchange filing.

What revenue was reported in Kwality Pharmaceuticals Q2 Results FY27?

Ans. Kwality Pharmaceuticals reported consolidated revenue of Rs 181.22 Cr in Q2 FY27, compared with Rs 111.05 Cr a year earlier. This comparison appears in the Financial Highlights table and in the performance analysis.

What net profit was reported in Kwality Pharmaceuticals Q2 Results FY27?

Ans. Kwality Pharmaceuticals reported net profit of Rs 29.03 Cr in the quarter, against Rs 14.12 Cr a year earlier. This net profit figure is covered in the Key Takeaways section.

How much YoY growth did revenue show in Kwality Pharmaceuticals Q2 Results FY27?

Ans. Revenue showed YoY growth of 63.19% in the quarter, moving from Rs 111.05 Cr to Rs 181.22 Cr. Alongside this, net profit grew 105.59%, as the performance analysis explains.

Did net profit rise or fall in Kwality Pharmaceuticals Q2 Results?

Ans. In Kwality Pharmaceuticals Q2 Results, net profit rose to Rs 29.03 Cr from Rs 14.12 Cr, a gain of 105.59% YoY. This means profit grew faster than revenue, as the performance analysis shows.

What was the Operating Profit in Kwality Pharmaceuticals Q2 Results FY27?

Ans. Operating Profit for Kwality Pharmaceuticals was Rs 49.8 Cr, up 96.45% from Rs 25.35 Cr a year earlier. This line is also listed among the Key Takeaways from the results.

Are Kwality Pharmaceuticals Q2 Results consolidated results or standalone results?

Ans. Kwality Pharmaceuticals Q2 Results are consolidated results, covering the company on a consolidated basis. This basis is stated in the Quick Answer and applies to every figure in the Financial Highlights table.

What business factors shaped Kwality Pharmaceuticals Q2 Results FY27?

Ans. Kwality Pharmaceuticals disclosed revenue growth of 63.2%, net profit growth of 105.6% and a net profit margin of 16.0% from 12.7%. These drivers are detailed in the Key Business Factors section.

What are the key risks after Kwality Pharmaceuticals Q2 Results FY27?

Ans. Quarterly net profit has been volatile over the last 5 quarters, and annual per-share profit has fallen across FY22 to FY26. These risks are set out in the Key Risks to Watch section.

What is the outlook after Kwality Pharmaceuticals Q2 Results?

Ans. FY27 full-year results will depend on subsequent quarters and on disclosed sector conditions. This outlook section notes that revenue has risen in each of the last 4 quarters.

Where can I find the complete Kwality Pharmaceuticals Q2 Results FY27 data?

Ans. The complete figures sit in the Financial Highlights table above, which compares each metric with the same quarter last year. Readers can also use the Univest Screener for further quarterly results.